Skip to main content

Treatment

Memantine (Namenda)

Quick answer

An NMDA receptor modulator used in moderate to severe Alzheimer's disease, often alongside a cholinesterase inhibitor.

Author:
Illinois Dementia Guide editorial team
Medically reviewed by:
Amarish Dave, DO, Board Certified Neurologist
Published:
August 2026
Last medically reviewed:
August 2026
Geographic relevance:
Illinois, United States

Overview

Memantine works through a different mechanism than cholinesterase inhibitors and is generally well tolerated.

Practical points

  • Often combined with donepezil
  • Dose titrated over several weeks
  • Adjusted in significant kidney disease

Common side effects

  • Dizziness
  • Headache
  • Confusion or agitation in a minority of patients
  • Constipation

Medically reviewed. Last reviewed August 2026. This page is educational information, not individualized medical advice.

Find help near you in Illinois